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Abstract. A study of the problem of structural variants of proteins and their relative 
contribution to the expressed immunological and biological activity has been initiated using 
sheep and buffalo prolactins as models. The feasibility of obtaining immunologically and 
biologically active prolactin in high yields from the discarded 'acid pellet' of sheep and 
buffalo pituitaries has been demonstrated. This permits use of the same batch of glands for 
purifying lutropin, follitropin and prolactin as side fractions. The major component in 
preparations of buffalo prolactin has a molecular size of 24 kDa. The preparations were 
active in a radioligand binding inhibition assay and in a rat liver based radioreceptor assay. 
Charge and size isomers of sheep prolactin and buffalo prolactin have been observed. The 
reference sheep prolactin did not, in preliminary work, give any indication of being glyco-
sylated. However radioactive sulphate was found to be incorporated into prolactin-rich 
fractions of sheep and buffalo pituitaries in vitro. By physico-chemical and immunochemical 
criteria the [35S]-labelled material was similar to standard reference prolactin. The 
structural  implications  of  sulphation  have  been  probed. 
 
Introduction 
 
The pituitary polypeptide hormone prolactin (PRL) plays an important but 
enigmatic physiological role in all vertebrates from fish to mammals (Ensor, 1978). 
Over 80 biological effects have been ascribed to PRL (Nicoll et al., 1986). Inspite of 
an astonishingly large body of information on its structure, biosynthesis, secretion 
and physiological action, nothing is understood regarding either the mechanism of 
its action or the relation of its structural domains to biological effects (Nicoll et al., 
1986). 
A number of reports have claimed detection of multiple forms of PRL. These 
reports have identified size differences among these structural variants. Recently, 
Lewis et al. (1984) reported the detection and purification of a glycosylated form of 
ovine PRL. However, a detailed study of the origin and relative contribution of the 
different polymorphic forms of PRL to its expressed biological and immunological 
activity  has  not  been  made  till now. 
We have recently initiated a programme of study of PRL from buffalo. Our aim in 
this study was to relate the structural domains of buffalo PRL to physiologically and 
immunologically important epitopes especially from an evolutionary perspective. 
The bewildering variety of its actions—osmoregulation in fish, somatotropic action 
in amphibians, parental and migratory behaviour in birds, growth and tissue regene 
ration promotion in reptiles and luteotropic and luteolytic effects in mammals— 
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justified such a study. We report here the purification and physico-chemical chara- 
cterisation  of  PRL  from  frozen  pituitaries  of  sheep  and  buffalo. 
 
Materials and methods 
 
Hormones,  chemicals,  antisera and animals 
 
Sheep PRL for radioiodination and rabbit anti-ovine PRL serum for radioimmuno-
assay (RIA) were obtained through the courtesy of Dr. S. Raiti, National Institute of 
Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) Bethesda, Maryland, 
USA. Enzyme (penicillinase)—human PRL conjugate, rabbit anti-human PRL and 
goat anti rabbit γ-globulin were provided by Dr. G. L. Kumari of the National 
Institute of Health and Family Welfare, New Delhi. Ovine PRL (average of 
35 IU/mg), reference marker proteins for sodium dodecyl sulphate (SDS)-polyacryl-
amide gel electrophoresis (PAGE), bovine serum albumin (BSA), Sephadex-G50, 
DEAE Sephadex-A50, acrylamide, bis acrylamide, TEMED, Freund's complete 
adjuvant, ammonium persulphate, Coomassie blue R-250, concanavalin A (ConA)-
Sepharose and α-methyl-D-mannoside were purchased from Sigma Chemical 
Company, St. Louis, Missouri, USA. Carrier-free Na 125 I and carrier-free 35 SO42–  
were obtained from Bhabha Atomic Research Centre, Bombay. PPO and dimethyl 
POPOP were purchased from SISCO research laboratories, Bombay. The WHO 
reference standard ovine PRL (22 IU/mg) was obtained through the National 
Institute of Biological Standards, England. Adult rats employed in this study were of 
Holtzman strain, and were maintained     in our colony under standard 14 h L: 10 h D 
schedule. They were given food (Hindustan Lever Ltd., Bombay) and water ad 
libitum. Male albino rabbits weighing 2·5 kg were purchased from Maulana Azad 
Medical College, New Delhi. All chemicals used in this study, unless otherwise 
mentioned  were  of  Excelar/GR  grade. 
 
Pituitary  incubations  in vitro 
 
Incubations for examining 35SO42–  incorporation were carried out using minces of 
sheep and buffalo pituitaries collected fresh from a local abattoir. All  incubations 
were done at 37°C in a metabolic shaker and in modified KRBG buffer 
(Arunasmithasri et al., 1983). In sulphate incorporation studies MgSO4 was replaced 
by MgCl2. All media included amino acid and vitamin mixture as in Medium 199 
(Morgan  et  al., 1950). 
 
Purification  of  PRL 
 
Glands were collected from sheep and buffaloes which were being slaughtered at
a local abattoir. They were frozen in liquid N2 within 1 h of slaughter and trans-
ported to the laboratory in liquid N2 for processing. The procedures were
adaptations of those of Papkoff et al. (1965), Li (1974), NaiSiang-Jiang and Wilhelmi 
(1965) and Bell et al. (1985) with a few modifications. Briefly, the glands were minced
and homogenised in 0·15 Μ (NH4)2SO4 in a Waring blender and the homogenate
centrifuged at 3000 g for 20 min at 4°C. The pH of the supernatant was successively 
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adjusted to pH 4 and pH 3 followed each time by centrifugation at 3000 g for 15 min 
at 4°C. The pellets, called acid pellet, were tested as sources of PRL. The 
supernatants were used for the purification of lutropin (LH) and follitropin (FSH). In 
the adaptation of the NaiSiang-Jiang and Wilhelmi (1965) procedure, chilled 
(–20°C) alkaline ethanol (pH 9·5) was added to the pH 4 acid pellet and the two 
were mixed well. The suspension was centrifuged. To the supernatant at pH 5·5 were 
added 2 volumes of chilled ethanol to precipitate enriched PRL (P-l fraction). This 
precipitate, collected by centrifugation, was dissolved and dialysed against weak 
ammonium bicarbonate and lyophilised. The material was then subjected to 
chromatography on DEAE Sephadex equilibrated with 0·01 Μ phosphate-0·0065 Μ 
borate buffer, pH 7. The bound proteins were eluted with a step wise gradient of 
NaCl. In the adaptation of the procedure of Li (1974), the pH 4 acid pellet was 
extracted with acidic acetone followed by the precipitation of PRL with a further 5 
volumes of chilled acetone. The precipitate was dissolved and subjected to 
differential isoelectric precipitation by gradual adjustment of pH (figure 1). The 
 
Figure 1. 
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procedure of Bell et al. (1985) involved extraction of the pH 4 acid pellet with 10 mM 
NH4HCO3-1 mM EDTA followed by chromatography of the extract directly on 
DEAE  Sephadex. 
 
Disc electrophoresis 
 
Electrophoresis under denaturing conditions was carried out essentially according to 
the procedure of Laemmli (1970) using 11% resolving gels. Disc electrophoresis in 
native gels was carried out according to the method of Davis (1964). Electrophoretic 
transfer of proteins from gels onto nitrocellulose paper was carried out according to 
the procedure of Towbin et al. (1979) except that 80 mA current was used for 12 h and 
Whatman No. 1 filter sheets were employed for padding. Immuno-staining was 
carried out by the use of biotinylated second antibody and biotinylated peroxidase-
avidin system as described by Vector Laboratories, USA (Hsu et al., 1981). A 1:100 
dilution  of  the  rabbit  antibody  (local) was used. 
 
Con  A-Sepharose  chromatography 
 
Affinity chromatography on Con A-Sepharose was performed according to the 
Standard  procedure  of  Bloomfield  et  al.  (1978)  at  pH 6.
 
Antiserum 
 
Antiserum to commercial ovine PRL (Sigma Chemicals, USA) was raised in rabbits 
essentially according to the procedure of Vaitukaitis  et  al.  (1971).
 
Immunoprecipitation 
 
Incubation of minces from sheep and buffalo pituitary glands (4–5/flask) was carried 
out in 10–20 ml of modified KRBG in the presence of radioactive sulphate 
(200 µCi/ml). At the end of the incubation the tissue was homogenised and processed 
as in the case of bulk preparation of PRL. The dialysed P-l fraction (figure 1) was 
taken for immunoprecipitations. 35S-Labelled proteins from this fraction (165– 
200 µg protein containing 2000–2500 cpm) were incubated with excess of rabbit 
antiserum to PRL or normal rabbit serum for 1 h at 37°C and 3 days at 4°C. The 
buffer used was 0·01 Μ phosphate buffered saline, pH 7·5. The immunoprecipitate 
was collected by centrifugation at 3000 g for 15 min at 4°C, washed with chilled 
physiological saline by centrifugation, and dissolved in a small volume of 0·05 Ν 
NaOH. Aliquots were then taken for radioactivity measurement. In the case of the 
incubation medium, it was dialysed extensively and then lyophilised. The lyophilised 
powder was then subjected to immunoprecipitation as above.
 
Radioiodination and radioligand binding inhibition test
 
Radioiodination of ovine PRL (NIH Standard) was performed essentially according to
the method of Greenwood et al. (1963). A specific activity of 25-30 µCi/µg was
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maintained for both RIA and radioreceptor assay (RRA). Radioligand binding 
inhibition test was carried out using 125I-labelled ovine PRL (NIH standard) and 
rabbit antiserum to ovine PRL (NIH product) at 1:25,000 initial dilution. Reference 
(ovine)  and  buffalo  PRL  were  used  for  competitive  binding  inhibition. 
 
RRA 
 
This was carried out using rat liver homogenate as a source of PRL receptors 
essentially according to the method of Taga (1982) with slight modifications. Briefly, 
300 µl of rat liver homogenate, 100 µl of 125I-labelled ovine PRL (80,000 cpm) and 
100 µl of a serially diluted ovine PRL standard or the unknown sample were 
incubated in 0·025 Μ buffer, pH 7·6/10 mM CaCl2/0·1 % BSA at 37°C for 2h 
followed by the addition of 2 ml of the RRA buffer. The tubes (10 × 75 mm) were 
centrifuged in a Sorvall RC-2B centrifuge at 3000 g for 15 min at 4°C. The super-
natants were discarded and after wiping the sides free of adhering liquid, the 
pellets were counted for radioactivity in an ECIL type manual counter at 70% 
efficiency.  Suitable  controls  were  included. 
 
Enzyme immunoassay 
 
The enzyme immunoassay (EIA) was performed according to a method standardized 
in the laboratory. Briefly 100 µl of anti human PRL serum (1:50,000 dilution) and 
100 µl of reference human PRL (serially diluted, 100-4000 pg/tube) or the unknown 
were incubated for 16 h in 0·01 Μ phosphate-buffered saline, pH 7 containing 0·05% 
BSA, 0·1% sodium azide and 0·05% (v/v) Tween 20. At the end of the incubation, 100 µl 
of 1:2000 diluted enzyme (penicillinase)—PRL conjugate (1 mg/ml stock) was added, 
and incubation continued for 6 h at 37°C. Then goat anti-rabbit g-globulin serum 
(1: 3 0 dilution) was added to all tubes followed by incubation for 36 h. The tubes 
were centrifuged and supernatants discarded. The substrate solution (1 mM) 
followed 1 h later by the starch-I2 reagent were added. After 10 min, the reaction was 
terminated by the addition of 5 Ν HCl (1 ml/tube) and the colour developed was 
read  at  620  nm  in  a  spectrophotometer. 
 
Results and discussion 
 
We had initially examined the feasibility of purifying PRL from freshly frozen buffalo 
pituitary glands. As there was no previous work on PRL from this animal species, we 
tested procedures published for sheep, cattle and pigs (NaiSiang Jiang and Wilhelmi, 
1965; Li, 1974; Bell et al., 1985). We had earlier shown that the procedure of Papkoff 
et al. (1965) for the purification of ovine LH was applicable with a few modifications 
to buffalo pituitary glands (Arunasmithasri et al., 1983; Muralidhar and
Rajendrakumar, 1986). In the course of the work on LH, the chance observation was 
made that the acid pellet—the fraction usually discarded in the procedure employed 
for LH purification—was reacting positively with a specific rabbit antiserum to
ovine PRL (Neeraja Chadha et al., 1987). Surprisingly, the pH 4 acid pellet gave a
precipitin line against anti-PRL serum in Ouchterlony immunodiffusion test while
the pH 3 acid pellet did not (data not shown). The antiserum was raised against a
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commercially available ovine PRL and was decomplemented and then absorbed 
with normal sheep serum (Muralidhar et al., 1974) before use; the absorbed 
antiserum did not give a line against bovine growth hormone (data not shown). 
This result indicated that the pH 4 acid pellet could be a convenient source 
of PRL. This was indeed true for buffalo glands also. We obtained highly enriched 
PRL from this fraction by simply applying the published procedures for pituitaries of 
sheep, cattle and pigs with a few modifications to the pH 4 acid pellet (figure 1). 
Procedures 1, 2, 3 in the figure 1 refer to combination of the procedure of Papkoff et al. 
(1965) with those of NaiSiang Jaing and Wilhelmi (1965), Li (1974) and Bell et al. 
(1985), respectively. These preparations are referred to respectively as bu-P-W-P-1, 
bu-P-Li and bu-P-B in table 1. The procedure of Bell et al. (1985) did not yield any 
immunoreactive material from the acid pellet of sheep pituitary glands but was useful 
for the buffalo acid pellet. The procedures of NaiSiang Jiang and Wilhelmi (1965) 
and of Li (1974) were equally applicable to the acid pellets of sheep and buffalo 
glands. The material designated as P-l was highly enriched in PRL as indicated by 
RIA estimatable PRL which was obtained in high yields (table 1). The combination 
of the procedures of Papkoff et al. (1965) and NaiSiang Jiang and Wilhelmi (1965) 
worked well for obtaining PRL from both sheep and buffalo acid pellet. It was, for 
buffalo and sheep pituitary glands, a single fractionation scheme which yielded LH, 
FSH and PRL as different fractions. NaiSiang Jiang and Wilhelmi (1965) who 
combined the classical scheme of Ellis (1961) with a few additional steps reported 
good yields of PRL from ovine, bovine and porcine pituitary glands. However they 
did not report purification of LH and FSH also from the same batch of glands. We 
have established recently that their scheme of purification starting from Ellis (1961) 
fractionation procedure also yields highly enriched PRL from buffalo pituitary 
glands  (table 1, bu-E-W-P-1). 
 
 
Table 1. Yield of PRL (immunoreactive) in the procedures 
using acid pellet as starting material. 
 
 
o, ovine; bu, buffalo; P, Papkoff et al. (1965) procedure; Li, 
procedure of Li (1974); B, procedure of Bell et al. (1985); W, 
Wilhelmi; Ε, Ellis (1965) procedure. 
 
 
All the preparations were active in a radioligand binding inhibition test using  125I - 
labelled ovine PRL, rabbit anti-ovine-PRL serum and ovine-PRL as reference
standard (table 2). Though they were tested at the same dose, the degrees of
inhibition were different. As there was obviously no relation to purity (for example
the NIDDK sample is iodination grade but has only 66% activity), the difference in
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Table 2. Effectiveness of different buffalo PRL pre- 
parations  in  a  radioligand  binding  inhibition test. 
125I-ovine PRL (NIDDK sample) and different 
PRLs (5 ng/tube level) were incubated with anti- 
ovine PRL serum and bound radioactivity measured.  
 
*E, Ellis procedure. For other abbreviations see table I. 
 
degree of inhibition reflects the different avidities of the antiserum for these prepa- 
rations. This in turn reflects the differences in antigenic epitope. If they indeed
represent the in vivo situation, it would be extremely interesting. We are presently
trying to develop a homologous RIA system for buffalo PRL. The buffalo pituitary
PRL's (all the preparations) did not cross react with human PRL when tested in
an EIA. The results are given in table 3. The absorbance values obtained for the
 
Table 3. Absence of cross reaction between buffalo and 
human  PRL  in  an  EIA.  
 
different preparations of PRLs were around the same as that indicated in table 3 for 
bu-P-W-P-l0·2M. Aston and Ivanyi (1985) in a study of human PRL using mono-
clonal antibodies have shown that two of them could bind both human and bovine/ 
ovine PRL in a labelled antibody competition test. This would mean that even 
without selection by using 125I-labelled ovine PRL for screening hybridoma 
supernatants containing secreted antibodies against human PRL, one can obtain 
cross-reaction between human and non-primate PRL. In our test we used a poly- 
clonal antiserum, and it is possible that the cross-reacting antibodies were in too low 
a  concentration  to  be  detected  in  a  competitive  test. 
The buffalo PRL preparations were also active in a rat liver based RRA (Taga,
1982). Figure 2 illustrates the results with reference PRL and with buffalo PRL
prepared by the combination of the procedures of Papkoff et al. (1965) and Li (1974). 
The results also indicate that bovine growth hormone (GH) not exhibit significant
activity in the range tested. Approximately 5000 ng of GH were needed to cause 50% 
inhibition of the binding of 125I-labelled ovine PRL while bu-P-Li5·6 and ovine PRL 
could do so at approximately 84 and 25 ng, respectively. This indicates that GH has 
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Figure 2. Radioreceptor assay for PRL using rat liver homogenate as a source of 
receptors.  (•),  ovine PRL  (Sigma);  (O), buffalo  PRL  (bu-P-Li5.6);  (∆),  bovine GH.
 
 
less than 0·5% activity in this assay system. It also proves that although the 
purification of buffalo PRL was monitored by immunological activity, the 
preparation was biologically active in a receptor system specific to PRL and hence is 
not  a  cross-reacting  substance. 
It was possible to further purify the P-l preparation by subjecting it to DEAE-
Sephadex chromatography. A representative chromatographic profile for the bu-P- 
W-P-l preparation is given in figure 3. It can be seen that PRL gets bound to the
column  and  is  eluted  with  0·2 Μ NaCl. 
Although we do not have evidence it is possible that there was a biologically
active but immunologically inactive PRL in other fractions. Immunologically poor
 
 
Figure 3. DEAE-Sephadex chromatographic profile of buffalo PRL (bu-P-W-P-1), 40 mg 
of bu-P-W-P-1 was loaded on DEAE-Sephadex column (1 × 40cm) at 4°C and the flow 
rate was 30 ml/h. Arrows indicate the points of start of salt gradient (stepwise). The shaded 
area represents the purified PRL. Sample was loaded in 0·01 ΜΡΟ4-0·0065 Μ borate pH 7. 
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but biologically very active forms of mouse PRL, for example, have been reported 
(Sinha  and  Baxter,  1979). 
It must also be mentioned that only the Papkoff–Wilhelmi procedure gave a PRL 
which was eluted from DEAE Sephadex at 0·2 Μ NaCl. The procedure of Bell et al. 
(1985) gave a PRL which was eluted from DEAE Sephadex only with 
0·5 Μ NH4 HCO3. It is possible that prolonged exposure to NH4 HCO3 in this 
procedure caused some deamidation giving rise to more acidic forms of PRL.
However, isoelectric focusing has not been done yet to substantiate this idea. In the 
procedure of Li (1974) also, while the sheep acid pellet gave us a PRL which
precipitated at pH 5·6, the buffalo acid pellet gave one at 5·6 (bu-P-Li5.6) and
another immunoreactive PRL at pH 2·3 (bu-P-Li2.3). These results indicate the 
possible presence of charged isomers of PRL. Many reports in the literature do point 
to such a situation based on electrophoretic analysis of PRL in native gels. We have 
also found that the reference standard PRL (Sigma) and our 0·2 Μ fraction of bu–P– 
W–P-l show multiple bands on electrophoresis in native gels (figure 4). However, by 
 
 
Figure 4. Electrophoretic profile (Coomassie blue bands) of P-l (left lane) and reference 
PRL  (right  lane)  in native gels. 
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Western blotting, these forms were found to be immunologically same (data not 
shown). Direct evidence that these are deamidated forms has been provided by the 
study of Graf et al. (1970) who isolated two forms of PRL, a normal and a faster mov- 
ing band. Peptide maps showed that the two forms differed only in one peptide spot. 
The difference was found to be attributable to Asn/Asp content. Whether deamida-
tion occurs within cells or in the blood (enzymatic or otherwise) and if so, its physio- 
logical significance, are not known. Reports of altered immunological and receptor 
binding properties of the deamidated form of mouse PRL, however, do exist in the 
literature  (Haro  and  Talamantes,  1985). 
In view of the report of Lewis et al. (1984) of the existence of glycosylated forms of 
ovine PRL, we examined the commercial preparation of ovine PRL. We found no 
evidence for the presence of glycosylated forms. Neither the hormone nor even the 
125I-labelled ovine PRL was found to be retained on a Con A-Sepharose affinity 
column. Less than 1 % of the loaded material was found retained. There was no 
directly estimatable sugar in the dialysed preparation (Neeraja Chadha and 
K. Muralidhar, unpublished results). It gave two closely moving Coomassie blue 
stainable bands in SDS-PAGE indicating a difference in molecular size of about 
1500-2000. The 0·2 Μ fraction from DEAE-Sephadex chromatography also gave a 
similar pattern (data not shown). However on immunoblotting after electrophoretic 
transfer, both  the  bands reacted with  the  antibody  (figure 5, left  and  right  lanes). 
Based on our previous experience with the glycoprotein hormone LH, metabolic 
studies were conducted to throw additional light on the problem of size variation
due to glycosylation. We had earlier demonstrated by physico-chemical, immuno-
logical and biological criteria that pituitary LH has sugar-bound sulphate
(Arunasmithasri et al., 1983; Rajyalakshmi et al., 1983; Muralidhar and
Rajendrakumar, 1986). A chance observation that significant radioactivity was
present in the PRL rich fraction made us investigate this further. To our surprise we 
found that pituitary minces from sheep and buffaloes incorporate 35 SO42– from the 
incubation medium into immunoprecipitable PRL-like material. Both tissue and 
incubation medium yielded labelled immuno-precipitate (Rita Kohli et al., 1987). The 
material could be subjected to a fractionation scheme like that for purification of
PRL and radioactivity was still associated with purified PRL (Rita Kohli et al., 1987).  
The 35S-labelled proteins from the sheep pituitary tissue were extracted, purified to 
the P-l stage and then subjected to SDS-PAGE analysis. Parallel strips were taken 
for staining, slicing and counting for radioactivity and also for slicing and extraction 
for immunodiffusion tests. From table 4 it is obvious that there are a number of 35S- 
labelled proteins in the P-l fraction. Two of these are of interest. They had molecular 
size in the region of 25 kDa but differing by 1500–2000 (figure 5). Interestingly both 
the proteins gave precipitin lines in the Ouchterlony test (figure 6). Protein from slice 
two (table 4) which had significant radioactivity did not react with anti-PRL serum. 
The Ouchterlony data was confirmed by Western blot analysis (figure 5, middle 
lane).  These  observations  raise  more  questions  rather  than  provide  answers. 
The nature of the linkage between sulphur and the PRL peptide backbone is not
clear. A number of possibilities exist: (i) both these bands (figure 5, middle lane) 
contain PRL with sugar-SO4, (ii) both the forms are tyrosine-SO4-containing PRL 
with the larger protein having a chemical modification leading to the size increase, 
and (iii) the larger protein is a sugar-SO4 4containing PRL while the smaller protein 
is a tyrosine-SO4 containing PRL. In the experiment demonstrating the absence of 
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Figure 5. Western blot picture of standard PRL (left lane), 35S-labelled P-l (middle lane) 
and 0·2 Μ fraction from DEAE-Sephadex chromatography (right lane). These were 
subjected  to  SDS-PAGE  and  then  transferred  to nitrocellulose sheet. 
 
adsorption on Con A Sepharose, a commercial preparation of sheep PRL was
used. The reason for invoking the presence of sugar-SO4 is that the 35S-labelled 
immuno reactive proteins may differ from the commercial preparation. However,
none of these alternatives point to the existence of the non-glycosylated and non-
sulphated PRL and 24 kDa known for over 40 years (Li, 1980). A 20 kDa PRL has 
been reported to be present in human pituitary extracts (Aston et al., 1984). Aston
and Ivanyi (1985) have shown that even affinity purified human PRL, i.e., PRL 
purified on monoclonal antibody affinity columns, gives multiple bands of Western
blots. Two bands, at 26 and 24 kDa positions, were predominant. Minor bands at 18, 
16 and 8 kDa positions were also noticed. The generation of these polypeptides was 
ascribed to proteolysis. Ovine PRL also gave the 26 and 24 kDa bands on similar 
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Table 4. Molecular size variation among 
35S-labelled sheep pituitary proteins (P-l 
fraction). 
Sheep pituitary minces were incubated in 
vitro with 35SO and at the end of the 
incubation the tissue was fractionated to 
yield P-l fraction. This was subjected to 
SDS-PAGE as per the procedure of 
Laemmli (I970) using II % preparative 
gels, 
 
 
*After subtracting background radioacti 
vity. 
 
 
 
Figure 6. Ouchterlony immunodiffusion test results, The central well had rabbit anti-ovine 
PRL serum and the surrounding wells had materials as follows: I2-O' clock well, Standard 
ovine PRL; 3-O' clock well, slice no. I3 extract; 6-O' clock well, slice no. I4 extract. All  the 
other wells had extracts from control slices taken arbitrarily from other portions of the 
SDS-PAGE slab gel. 
 
analysis. Bovine PRL gave a less intense 26 kDa band. There have been other reports
of the existence of size variants of PRL. These include aggregates (Squire et al., 1963; 
Nyberg et al., 1980; Niall, 1981), monomers with chemical modifications such as
glycosylation, phosphorylation etc. (Lewis et al., 1984; Butnev and Pankov, 1985;
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Oetting et al., 1986) and biosynthetic precursors (Lingappa et al., 1977). The relative 
contributions of these forms to the biological activity of the hormone have not been 
fully investigated. On the other hand, these forms may be experimental artifacts (e.g.
due to lyophilisation). However, size variants of proteins are known to arise as a 
result of alternative processing of mRNA, post-translational modifications, or 
proteolytic  in  circulation. 
In conclusion, it has been possible to obtain highly enriched preparations of PRL 
from the discarded acid pellets of sheep and buffalo pituitary glands. It was possible 
to obtain the PRL in a homogeneous form. Further purification of the PRL prepa- 
rations from sheep and buffalo glands is in progress. During these studies a number 
of polymorphic forms of PRL were noticed. Some were shown to be charged isomers 
while others were shown to differ in degree of sulphation and hence to be size 
isomers. The nature of the linkage between polypeptide and sulphur is being 
investigated.  It  could  be  sugar -SO4  or  tyrosine- SO4.  Further  work  is  in  progress. 
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